Sleepiness in Parkinson's Patients With Continuous Dopaminergic Delivery Device or Deep Brain Stimulation

Monitoring of Sleepiness in Patients With Parkinson's Disease Before and During Treatment With Continuous Dopaminergic Delivery Device or Deep Brain Stimulation

Sleepiness is frequent in parkinsonian patients, increasing with the duration of disease. By patients with motor fluctuations, continuous dopaminergic delivery devices or deep brain stimulation are justified to improve the motor prognosis. Antiparkinsonian treatments, especially dopaminergic agonists, may worsen the sleepiness and thus affect the quality of life. The investigators aimed to monitor sleepiness in parkinsonian patients before and during treatment with continous dopaminergic delivery device or deep brain stimulation.

Inclusion Criteria:

• patient with Parkinson's disease and motor fluctuations
• and indicated for a continuous dopaminergic delivery device or deep brain stimulation

Exclusion Criteria:

• age < 18 years
• refusal for the continuous dopaminergic delivery device or deep brain stimulation
• wake-promoting drugs intake
• refusal to participate
• legal protection
• uncontrolled sleep apnea